Retrofitted antibodies with stabilizing mutations: Herceptin scFv mutant with VH K30D and VL S52D.
External Resource: Annotation
| Chains | Family Name | Domain Identifier | Architecture | Possible Homology | Homology | Topology | Family | Provenance Source (Version) |
| D | ANAPC4_WD40, Beta-prop_WDR36-Utp21_1st | e6dn0D1 | A: alpha bundles | X: P-loop domains-like | H: P-loop domains-related | T: P-loop containing nucleoside triphosphate hydrolases | F: ANAPC4_WD40, Beta-prop_WDR36-Utp21_1st | ECOD (develop294) |
| B | DAO | e6dn0B1 | A: alpha bundles | X: P-loop domains-like | H: P-loop domains-related | T: P-loop containing nucleoside triphosphate hydrolases | F: DAO | ECOD (develop294) |
| C | ANAPC4_WD40, Beta-prop_WDR36-Utp21_1st | e6dn0C1 | A: alpha bundles | X: P-loop domains-like | H: P-loop domains-related | T: P-loop containing nucleoside triphosphate hydrolases | F: ANAPC4_WD40, Beta-prop_WDR36-Utp21_1st | ECOD (develop294) |
| A | DAO | e6dn0A1 | A: alpha bundles | X: P-loop domains-like | H: P-loop domains-related | T: P-loop containing nucleoside triphosphate hydrolases | F: DAO | ECOD (develop294) |
| Chain | Protein Name | Description | Organism Name | Gene Allele Name(s) | Domain Name(s) | Receptor Type | Receptor Description | Provenance Source |
|---|
| | Fv Herceptin mutant VH K30D and VL S52D | V-KAPPA | Homo sapiens (human) | IGKV1-39*01, IGKV1D-39*01, IGKJ1*01 | V-DOMAIN V-KAPPA | IG | FV-HEAVY_KAPPA | IMGT (202610-0) |
| | Fv Herceptin mutant VH K30D and VL S52D | VH | Homo sapiens (human) | IGHV3-66*01, IGHV3-66*02, IGHV3-66*04, IGHJ1*01 | V-DOMAIN VH | IG | FV-HEAVY_KAPPA | IMGT (202610-0) |
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|
| | Light Chain | IGKV1 | Kappa | - | SAbDab (2026-03-20) |
| | Heavy Chain | IGHV3 | - | - | SAbDab (2026-03-20) |
| Chain | Name | Target | Provenance Source |
|---|
| Caxmotabart | ERBB2/CD340/HER2, TNFRSF9/CD137/4-1BB, SIRPA, CD3E | Therapeutic SAbDab (2026-03-20) |
| Trastuzumab | ERBB2/CD340/HER2, TNFRSF9/CD137/4-1BB, SIRPA, CD3E | Therapeutic SAbDab (2026-03-20) |